JMP Securities reiterated its Market Outperform rating and $7.00 price target for Esperion Therapeutics (NASDAQ:ESPR) stock, ...

JMP Securities adjusted its price targets for two key players in the residential mortgage REIT industry. MFA Financial, Inc. (NYSE:MFA) saw its price target reduced to $12.50 from $13.50, while ...

JMP Securities analyst Steven DeLaney lowered the firm’s price target on Redwood Trust (RWT) to $8 from $9 and keeps an Outperform rating on ...

JMP Securities analyst Matthew Carletti reiterated a Hold rating on RLI (RLI – Research Report) today. The company’s shares closed yesterday at ...

On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $2.92 which represents a decrease of $-0.24 or -7.59% from the prior close of $3.16. The stock opened at $3.17 and ...

JMP Securities reissued their market outperform rating on shares of Century Casinos (NASDAQ:CNTY – Free Report) in a report ...

JMP Securities restated their market outperform rating on shares of Churchill Downs (NASDAQ:CHDN – Free Report) in a report ...

Rocket Lab USA Inc (RKLB) stock saw a modest uptick, ending the day at $31.27 which represents a slight increase of $7.27 or 30.29% from the prior close of $24. The stock opened at $26 and touched a ...

Benchmark believes that Roku can benefit meaningfully from establishing partnerships with other platforms and further ...

JMP Securities initiated coverage of Context Therapeutics (CNTX) with an Outperform rating and $4 price target Context is a $97.8M market cap clinical-stage biotechnology company focused on ...

JMP Securities analyst Silvan Tuerkcan initiated coverage of Solid Biosciences (SLDB) with an Outperform rating and $15 price target Solid is a clinical-stage biotechnology company focused on ...

Nuveen Churchill Direct Lending Corp. (the "Company," "we," "us," or "our") (NYSE: NCDL) today announced that it has closed a public offering of $300.0 million aggregate principal amount of 6.650% ...